Protocol biopsy-driven interventions after pediatric renal transplantation

Pediatric Transplantation

Volumn 14, Issue 8, 2010, Pages 1012-1018

  Kanzelmeyer, N K ^a   Ahlenstiel, T ^a   Drube, J ^a   Froede, K ^a   Kreuzer, M ^a   Broecker, V ^a   Ehrich, J H H ^a   Melk, A ^a   Pape, L ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Banff classification; long term outcome; protocol biopsy; renal transplantation

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; EVEROLIMUS; FUROSEMIDE; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; BLOOD TRANSFUSION; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEMATOMA; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY GRAFT REJECTION; KIDNEY INFECTION; KIDNEY TRANSPLANTATION; LONG TERM CARE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; POLYOMA NEPHROPATHY; POLYOMAVIRUS INFECTION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; SCHOOL CHILD;

AGE FACTORS; ALGORITHMS; ANALYSIS OF VARIANCE; BIOPSY; CALCINEURIN; CHILD; CLINICAL PROTOCOLS; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS;

EID: 78649843933     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01399.x     Document Type: Article

References (19)

1. Schwarz A, Mengel M, Gwinner W, et al. Risk factor for chronic allograft nephropathy after renal transplantation: A protocol biopsy study. Kidney Int 2005: 67: 341-348.
2. Gwinner W, Hinzmann K, Erdbruegger U, et al. Acute tubular injury in protocol biopsies of renal grafts: Prevalence, associated factors and effect on long-term function. Am J Transplant 2008: 8: 1684-1693.
3. Gwinner W, Suppa S, Mengel M, et al. Early calcification of renal allografts detected by protocol biopsies: Causes and clinical implications. Am J Transplant 2005: 5: 1934-1941.
4. Legendre C, Thervet E, Skhiri H, et al. Histologic features of chronic allograft nephropathy revealed by protocol biopsies in kidney transplant recipients. Transplantation 1998: 65: 1506-1509.
5. Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR,. The natural history of chronic allograft nephropathy. N Engl J Med 2003: 11: 349.
6. Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin N, Cosimi AB,. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002: 346: 580-590.
7. NAPRTCS. Annual Report, 2008. Available at: (accessed May 1, 2010).
8. Birk PE, Stannard KM, Konrad HB, et al. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children. Pediatr Transplant 2004: 8: 29-38.
9. Rush D, Arlen D, Boucher A, et al. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: A randomized study. Am J Transplant 2007: 7: 2538-2545.
10. Schwartz GJ, Munoz A, Schneider MF, et al. New equations to GFR in children with CKD. J Am Soc Nephrol 2009: 20: 629-637.
11. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008: 8: 753-760.
12. Quist E, Their M, Krogerus L, Holmberg C, Jalanko H,. Early treatment of acute rejections gives favorable long-term function after renal transplantation in small children. Pediatr Transplant 2007: 11: 895-900.
13. Dart AB, Schall A, Gibson IW, Blydt-Hansen TD, Birk PE,. Patterns of chronic injury in pediatric renal allografts. Transplantation 2010: 89: 334-340.
14. Matas AJ,. Impact of acute rejection on development of chronic rejection in pediatric renal transplant recipients. Pediatr Transplant 2000: 4: 92-99.
15. Moreso F, Ibernon M, Gomá M, et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006: 6: 747-752.
16. Bosmans J-L, Ysebaert DK, Verpooten GA,. Chronic allograft nephropathy: What have we learned from protocol biopsies? Transplantation 2008: 85 (Suppl): 38-41.
17. Offner G, Tönshoff B, Höcker B, et al. Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. Transplantation 2008: 86: 1241-1248.
18. Grenda R, Watson A, Trompeter R, et al. A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: The TWIST study. Am J Transplant 2010: 10: 828-836.
19. Shapiro R, Randhawa P, Jordan ML, et al. An analysis of early renal transplant protocol biopsiesâthe high incidence of subclinical tubulitis. Am J Transplant 2001: 1: 47-50.